{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:24:57Z","timestamp":1794439497538,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T00:00:00Z","timestamp":1602547200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1245\/s10434-020-09216-9","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T13:03:45Z","timestamp":1602594225000},"page":"2451-2462","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":67,"title":["Financial Toxicity Following Surgical Treatment for Breast Cancer: A Cross-sectional Pilot Study"],"prefix":"10.1245","volume":"28","author":[{"suffix":"II","given":"Anaeze C.","family":"Offodile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malke","family":"Asaad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanos","family":"Boukovalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chad","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Li","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mediget","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A.","family":"Greenup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,13]]},"reference":[{"key":"9216_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2018.00227","author":"CWS Tong","year":"2018","unstructured":"Tong CWS, Wu M, Cho WCS, et al. Recent advances in the treatment of breast cancer. Front Oncol. 2018. https:\/\/doi.org\/10.3389\/fonc.2018.00227.","journal-title":"Front Oncol"},{"issue":"1","key":"9216_CR2","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3322\/caac.21551","volume":"69","author":"RL Siegel","year":"2019","unstructured":"Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin 2019; 69(1):7\u201334.","journal-title":"CA Cancer J Clin"},{"issue":"6","key":"9216_CR3","doi-asserted-by":"publisher","first-page":"438","DOI":"10.3322\/caac.21583","volume":"69","author":"CE DeSantis","year":"2019","unstructured":"DeSantis CE, Ma J, Gaudet MM, et al. Breast cancer statistics, 2019. CA Cancer J Clin 2019. 69(6):438\u2013451.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"9216_CR4","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1093\/jnci\/djq495","volume":"103","author":"A Mariotto","year":"2011","unstructured":"Mariotto A, Yabroff K, Shao Y, et al. Projections of the cost of cancer care in the U.S.: 2010\u20132020. J Natl Cancer Inst. 2011; 103(2):117\u2013128.","journal-title":"J Natl Cancer Inst"},{"issue":"18","key":"9216_CR5","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1002\/cncr.31532","volume":"124","author":"R Jagsi","year":"2018","unstructured":"Jagsi R, Ward KC, Abrahamse PH, et al. Unmet need for clinician engagement regarding financial toxicity after diagnosis of breast cancer. Cancer. 2018; 124(18):3668\u20133676.","journal-title":"Cancer"},{"issue":"12","key":"9216_CR6","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1200\/JCO.2013.53.0956","volume":"32","author":"R Jagsi","year":"2014","unstructured":"Jagsi R, Pottow JAE, Griffith KA, et al. Long-term financial burden of breast cancer: experiences of a diverse cohort of survivors identified through population-based registries. J Clin Oncol. 2014;32(12):1269\u201376.","journal-title":"J Clin Oncol."},{"issue":"4","key":"9216_CR7","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1634\/theoncologist.2012-0279","volume":"18","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Peppercorn JM, Schrag D, et al. The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient\u2019s experience. Oncologist. 2013;18(4):381\u2013390.","journal-title":"Oncologist."},{"issue":"1","key":"9216_CR8","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1002\/jso.25374","volume":"120","author":"R Lentz","year":"2019","unstructured":"Lentz R, Benson A, Kircher S. Financial toxicity in cancer care: prevalence, causes, consequences, and reduction strategies. J Surg Oncol. 2019;120(1):85\u201392.","journal-title":"J Surg Oncol"},{"issue":"3","key":"9216_CR9","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1007\/s40271-016-0204-x","volume":"10","author":"LG Gordon","year":"2017","unstructured":"Gordon LG, Merollini KMD, Lowe A, Chan RJ. A systematic review of financial toxicity among cancer survivors: we can\u2019t pay the co-pay. Patient. 2017;10(3):295\u2013309.","journal-title":"Patient."},{"issue":"4","key":"9216_CR10","doi-asserted-by":"publisher","first-page":"e50","DOI":"10.1200\/JOP.2011.000418","volume":"8","author":"AJ Bullock","year":"2012","unstructured":"Bullock AJ, Hofstatter EW, Yushak ML, Buss MK. Understanding patients\u2019 attitudes toward communication about the cost of cancer care. J Oncol Pract. 2012;8(4):e50\u20138.","journal-title":"J Oncol Pract"},{"issue":"10","key":"9216_CR11","doi-asserted-by":"publisher","first-page":"e408","DOI":"10.1016\/S2352-3026(15)00151-9","volume":"2","author":"SF Huntington","year":"2015","unstructured":"Huntington SF, Weiss BM, Vogl DT, et al. Financial toxicity in insured patients with multiple myeloma: a cross-sectional pilot study. Lancet Haematol. 2015;2(10):e408\u201316.","journal-title":"Lancet Haematol"},{"issue":"8","key":"9216_CR12","doi-asserted-by":"publisher","first-page":"e666","DOI":"10.1200\/JOP.18.00796","volume":"15","author":"RA Greenup","year":"2019","unstructured":"Greenup RA, Rushing C, Fish L, et al. Financial costs and burden related to decisions for breast cancer surgery. J Oncol Pract. 2019;15(8):e666\u2013e676.","journal-title":"J Oncol Pract"},{"issue":"20","key":"9216_CR13","doi-asserted-by":"publisher","first-page":"3245","DOI":"10.1002\/cncr.28814","volume":"120","author":"JA De Souza","year":"2014","unstructured":"De Souza JA, Yap BJ, Hlubocky FJ, et al. The development of a financial toxicity patient-reported outcome in cancer: the COST measure. Cancer. 2014; 120(20):3245\u201353.","journal-title":"Cancer"},{"issue":"3","key":"9216_CR14","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1002\/cncr.30369","volume":"123","author":"JA de Souza","year":"2017","unstructured":"de Souza JA, Yap BJ, Wroblewski K, et al. Measuring financial toxicity as a clinically relevant patient-reported outcome: the validation of the COmprehensive Score for financial Toxicity (COST). Cancer. 2017;123(3):476\u201384.","journal-title":"Cancer"},{"key":"9216_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1200\/JGO.19.11000","volume":"5","author":"K Honda","year":"2019","unstructured":"Honda K, Gyawali B, Ando M, et al. Prospective survey of financial toxicity measured by the comprehensive score for financial toxicity in japanese patients with cancer. J Glob Oncol. 2019;5:1\u20138.","journal-title":"J Glob Oncol"},{"issue":"1","key":"9216_CR16","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.ygyno.2019.04.003","volume":"154","author":"S Bouberhan","year":"2019","unstructured":"Bouberhan S, Shea M, Kennedy A, et al. Financial toxicity in gynecologic oncology. Gynecol Oncol. 2019;154(1):8\u201312.","journal-title":"Gynecol Oncol."},{"key":"9216_CR17","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djv410","author":"RD Tucker-Seeley","year":"2016","unstructured":"Tucker-Seeley RD, Yabroff KR. Minimizing the \u201cfinancial toxicity\u201d associated with cancer care: advancing the research agenda. J Natl Cancer Inst. 2016; https:\/\/doi.org\/10.1093\/jnci\/djv410.","journal-title":"J Natl Cancer Inst."},{"issue":"2","key":"9216_CR18","first-page":"80","volume":"27","author":"SY Zafar","year":"2013","unstructured":"Zafar SY, Abernethy AP. Financial toxicity, part I: a new name for a growing problem. Oncology (Williston Park). 2013;27(2):80\u20131.","journal-title":"Oncology (Williston Park)."},{"issue":"9","key":"9216_CR19","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1200\/JCO.2015.64.6620","volume":"34","author":"SD Ramsey","year":"2016","unstructured":"Ramsey SD, Bansal A, Fedorenko CR, et al. Financial insolvency as a risk factor for early mortality among patients with cancer. J Clin Oncol. 2016;34(9):980\u20136.","journal-title":"J Clin Oncol."},{"issue":"2","key":"9216_CR20","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1200\/JOP.2014.001542","volume":"11","author":"SY Zafar","year":"2015","unstructured":"Zafar SY, McNeil RB, Thomas CM, Lathan CS, Ayanian JZ, Provenzale D. Population-based assessment of cancer survivors\u2019 financial burden and quality of life: a prospective cohort study. J Oncol Pract. 2015;11(2):145\u201350.","journal-title":"J Oncol Pract."},{"issue":"15","key":"9216_CR21","doi-asserted-by":"publisher","first-page":"1732","DOI":"10.1200\/JCO.2015.63.2232","volume":"34","author":"CS Lathan","year":"2016","unstructured":"Lathan CS, Cronin A, Tucker-Seeley R, Zafar SY, Ayanian JZ, Schrag D. Association of financial strain with symptom burden and quality of life for patients with lung or colorectal cancer. J Clin Oncol. 2016;34(15):1732\u201340.","journal-title":"J Clin Oncol."},{"issue":"6","key":"9216_CR22","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1001\/jamaoncol.2016.4865","volume":"3","author":"AK Narang","year":"2017","unstructured":"Narang AK, Nicholas LH. Out-of-pocket spending and financial burden among medicare beneficiaries with cancer. JAMA Oncol. 2017;3(6):757\u201365.","journal-title":"JAMA Oncol."},{"issue":"6","key":"9216_CR23","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1002\/cncr.27848","volume":"119","author":"AJ Davidoff","year":"2013","unstructured":"Davidoff AJ, Erten M, Shaffer T, et al. Out-of-pocket health care expenditure burden for Medicare beneficiaries with cancer. Cancer. 2013;119(6):1257\u201365.","journal-title":"Cancer."},{"issue":"11","key":"9216_CR24","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1001\/jamaoncol.2017.2148","volume":"3","author":"F Chino","year":"2017","unstructured":"Chino F, Peppercorn JM, Rushing C, et al. Out-of-pocket costs, financial distress, and underinsurance in cancer care. JAMA Oncol. 2017;3(11):1582\u201384.","journal-title":"JAMA Oncol."},{"issue":"20","key":"9216_CR25","doi-asserted-by":"publisher","first-page":"3710","DOI":"10.1002\/cncr.28262","volume":"119","author":"EE Kent","year":"2013","unstructured":"Kent EE, Forsythe LP, Yabroff KR, et al. Are survivors who report cancer-related financial problems more likely to forgo or delay medical care? Cancer. 2013;119(20):3710\u20137.","journal-title":"Cancer."},{"issue":"1","key":"9216_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1257\/jep.29.1.139","volume":"29","author":"DH Howard","year":"2015","unstructured":"Howard DH, Bach PB, Berndt ER, Conti RM. Pricing in the market for anticancer drugs. J Econ Perspect. 2015;29(1):139\u201362.","journal-title":"J Econ Perspect."},{"issue":"22","key":"9216_CR27","doi-asserted-by":"publisher","first-page":"3900","DOI":"10.1002\/cncr.28321","volume":"119","author":"DW Light","year":"2013","unstructured":"Light DW, Kantarjian H. Market spiral pricing of cancer drugs. Cancer. 2013;119(22):3900\u20132.","journal-title":"Cancer."},{"issue":"4","key":"9216_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1016\/j.mayocp.2015.01.014","volume":"90","author":"H Kantarjian","year":"2015","unstructured":"Kantarjian H, Rajkumar SV. Why are cancer drugs so expensive in the United States, and what are the solutions? Mayo Clin Proc. 2015;90(4):500\u20134.","journal-title":"Mayo Clin Proc."},{"key":"9216_CR29","doi-asserted-by":"publisher","DOI":"10.1200\/jop.18.00120","author":"TG Knight","year":"2018","unstructured":"Knight TG, Deal AM, Dusetzina SB, et al. Financial toxicity in adults with cancer: adverse outcomes and noncompliance. J Oncol Pract. 2018. https:\/\/doi.org\/10.1200\/jop.18.00120.","journal-title":"J Oncol Pract"},{"issue":"3","key":"9216_CR30","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1007\/s11764-017-0669-1","volume":"12","author":"LT Dean","year":"2018","unstructured":"Dean LT, Schmitz KH, Frick KD, et al. Consumer credit as a novel marker for economic burden and health after cancer in a diverse population of breast cancer survivors in the USA. J Cancer Surviv. 2018;12(3):306\u201315.","journal-title":"J Cancer Surviv."},{"issue":"19","key":"9216_CR31","doi-asserted-by":"publisher","first-page":"3074","DOI":"10.1002\/cncr.28812","volume":"120","author":"SE Regenbogen","year":"2014","unstructured":"Regenbogen SE, Veenstra CM, Hawley ST, et al. The personal financial burden of complications after colorectal cancer surgery. Cancer. 2014;120(19):3074\u201381.","journal-title":"Cancer."},{"issue":"19","key":"9216_CR32","first-page":"3074","volume":"120","author":"AC Offodile","year":"2019","unstructured":"Offodile AC, Hwang ES, Greenup RA. Contralateral prophylactic mastectomy in the era of financial toxicity. Ann Surg. 2019;120(19):3074\u201381.","journal-title":"Ann Surg."},{"issue":"10","key":"9216_CR33","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.1245\/s10434-019-07594-3","volume":"26","author":"RA Greenup","year":"2019","unstructured":"Greenup RA, Rushing CN, Fish LJ, et al. Perspectives on the costs of cancer care: a survey of the American Society of Breast Surgeons. Ann Surg Oncol. 2019;26(10):3141\u201351.","journal-title":"Ann Surg Oncol"},{"issue":"11","key":"9216_CR34","doi-asserted-by":"publisher","first-page":"e944","DOI":"10.1200\/JOP.2017.022855","volume":"13","author":"WG Hunter","year":"2017","unstructured":"Hunter WG, Zafar SY, Hesson A, et al. Discussing health care expenses in the oncology clinic: analysis of cost conversations in outpatient encounters. J Oncol Pract. 2017;13(11):e944\u201356.","journal-title":"J Oncol Pract."},{"key":"9216_CR35","doi-asserted-by":"crossref","unstructured":"Meropol NJ, Schrag D, Smith TJ, et al. American Society of Clinical Oncology guidance statement: the cost of cancer care. J Clin Oncol. 2009;3868\u201374.","DOI":"10.1200\/JCO.2009.23.1183"},{"issue":"31","key":"9216_CR36","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1200\/JCO.2017.75.2311","volume":"35","author":"T Gilligan","year":"2017","unstructured":"Gilligan T, Coyle N, Frankel RM, et al. Patient-clinician communication: American Society of Clinical Oncology consensus guideline. J Clin Oncol. 2017;35(31):3618\u201332.","journal-title":"J Clin Oncol."},{"key":"9216_CR37","doi-asserted-by":"publisher","DOI":"10.17226\/18359","volume-title":"Delivering high-quality cancer care: charting a new course for a system in crisis","author":"L Levit","year":"2013","unstructured":"Levit L, Balogh E, Nass S. Delivering high-quality cancer care: charting a new course for a system in crisis. 2013. Washington (DC): National Academies Press."},{"key":"9216_CR38","doi-asserted-by":"publisher","first-page":"2977","DOI":"10.1007\/s00520-018-4605-3","volume":"27","author":"M Fitch","year":"2018","unstructured":"Fitch M, Zomer S, Lockwood G, Louzado C, Moxam RS, Rahal R, Green E. Experiences of adult cancer survivors in transitions. Support Care Cancer. 2018;27:2977\u201386.","journal-title":"Support Care Cancer"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1245\/s10434-020-09216-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-020-09216-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T22:58:39Z","timestamp":1669157919000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1245\/s10434-020-09216-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,13]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["9216"],"URL":"https:\/\/doi.org\/10.1245\/s10434-020-09216-9","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,13]]},"assertion":[{"value":"30 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The lead author (ACO) has received research funding from the Blue Cross Blue Shield Affordability Cures Consortium and National Academy of Medicine that are unrelated to the submitted work. He is also a board member of the Patient Advocate Foundation.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}}]}}